New product: Arikayce (amikacin) Liposomal 590 mg Nebuliser Dispersion

This inhalation suspension is licensed for the treatment of non-tuberculous mycobacterial lung infections caused by Mycobacterium avium Complex in adults with limited treatment options who do not have cystic fibrosis.

electronic Medicines compendium